Clinical trial
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
NCT06983743
Study timeline
Study start (actual)2025-06-05Date precision: day
Registry last updated2026-09-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Solid Tumorsunresolved
Interventions
Sponsors & collaborators
Erasca, Inc.lead sponsor
Merck Sharp & Dohme LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06983743 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.